ROCKWELL MEDICAL, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
ROCKWELL MEDICAL, INC. (RMTI) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $448.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $448.00K.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $549.00K.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $651.00K.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $753.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $448.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $549.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $651.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $753.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.07M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.21M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.34M 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.48M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.62M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.76M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.90M 10-K · filed 2025-03-20 |
| 2023-09-30 | $2.04M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.19M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.33M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.47M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |